About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Hims & Hers Health, Inc. (HIMS): Insider Trades and Fund Holdings
In the past 12 months, Hims & Hers Health, Inc. insiders reported 0 open-market purchases worth $0 and 14 sales worth $5.90M; 14 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Oct 14, 2026Insider saleGeneral Counsel Soleil Boughton sold $100,577 under a 10b5-1 plan (7 days after: executive or director change)
- Oct 14, 2026Planned saleBoughton Soleil (officer) filed notice to sell about $100,577 around Oct 14, 2026
- Oct 7, 2026NewsCompany reported: Executive or director change
- Oct 1, 2026Insider saleCFO Oluyemi Okupe sold $59,400 under a 10b5-1 plan
- Oct 1, 2026Planned saleOkupe Oluyemi (officer) filed notice to sell about $59,400 around Oct 1, 2026
- Sep 30, 2026Insider saleGeneral Counsel Soleil Boughton sold $100,957 under a 10b5-1 plan
- Sep 30, 2026Planned saleBoughton Soleil (officer) filed notice to sell about $100,957 around Sep 30, 2026
- Sep 22, 2026Insider saleCFO Oluyemi Okupe sold $876,846 under a 10b5-1 plan
- Sep 22, 2026Planned saleOkupe Oluyemi (officer) filed notice to sell about $876,846 around Sep 22, 2026
- Sep 17, 2026Insider saleCFO Oluyemi Okupe sold $354,861 under a 10b5-1 plan
- Sep 17, 2026Planned saleOkupe Oluyemi (officer) filed notice to sell about $354,861 around Sep 17, 2026
- Sep 16, 2026Insider saleGeneral Counsel Soleil Boughton sold $173,735 under a 10b5-1 plan
- Sep 16, 2026Planned saleBoughton Soleil (officer) filed notice to sell about $173,735 around Sep 16, 2026
- Sep 15, 2026Insider saleCOO Michael Chi sold $398,227 under a 10b5-1 plan
- Sep 15, 2026Insider saleCTO Mohamed Elshenawy sold $225,814 under a 10b5-1 plan
- Sep 15, 2026Planned saleChi Michael (officer) filed notice to sell about $398,227 around Sep 15, 2026
- Sep 15, 2026Planned saleElshenawy Mohamed (officer) filed notice to sell about $225,814 around Sep 15, 2026
- Sep 2, 2026Insider saleGeneral Counsel Soleil Boughton sold $97,965 under a 10b5-1 plan
- Sep 2, 2026Planned saleBoughton Soleil (officer) filed notice to sell about $97,965 around Sep 2, 2026
- Aug 19, 2026Insider saleGeneral Counsel Soleil Boughton sold $691,808 under a 10b5-1 plan
- Aug 19, 2026Insider saleCFO Oluyemi Okupe sold $148,111 under a 10b5-1 plan
- Aug 19, 2026Planned saleBoughton Soleil (officer) filed notice to sell about $691,808 around Aug 19, 2026
- Aug 18, 2026Insider saleChief Policy Officer Deborah M. Autor sold $467,128 under a 10b5-1 plan
- Aug 18, 2026Planned saleAutor Deborah M. (officer, director) filed notice to sell about $467,128 around Aug 18, 2026
- Aug 17, 2026Insider saleCFO Oluyemi Okupe sold $261,802 under a 10b5-1 plan
- Jun 30, 2026FundBridgewater Associates cut 83% in Q2 2026 (13F filed Aug 14, 2026)
- Jun 30, 2026FundRenaissance Technologies sold out in Q2 2026 (13F filed Aug 13, 2026)
- Jun 18, 2026Insider saleCFO Oluyemi Okupe sold $1.9 million under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 15, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 15 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $101K |
| Oct 2 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $101K |
| Oct 2 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $59K |
| Sep 23 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $877K |
| Sep 18 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $355K |
| Sep 17 | Michael ChiCOO | ▼ SELL10b5-1 | $398K |
| Sep 17 | Mohamed ElshenawyCTO | ▼ SELL10b5-1 | $226K |
| Sep 17 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $174K |
| Sep 3 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $98K |
| Aug 20 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $692K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Soleil Boughton | General Counsel | 0 | $0 | 5 | $1.17M |
| Oluyemi Okupe | CFO | 0 | $0 | 6 | $3.64M |
| Michael Chi | COO | 0 | $0 | 1 | $398K |
| Mohamed Elshenawy | CTO | 0 | $0 | 1 | $226K |
| Deborah M. Autor | Chief Policy Officer | 0 | $0 | 1 | $467K |
Buybacks and executive pay
Hims & Hers Health, Inc. spent $90 million buying back its own shares in 2025.
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $23.0M | $159.7M | n/a |
| 2024 | $24.6M | $110.3M | n/a |
| 2023 | $14.4M | $21.4M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
Tracked funds that report HIMS
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Bridgewater Associates | 7,036 | $244K | ▼ −83.1% |
| Renaissance Technologies | 0 | $0 | ▼ Sold out |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →